Ultragenyx Pharmaceutical (NasdaqGS:RARE) Q3 2025 Earnings Call November 04, 2025 05:00 PM ET Speaker10Good afternoon and welcome to the Ultragenyx Third Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. At the end of the prepared remarks, you will have an opportunity to ask questions during the Q&A portion of the call. It is now my pleasure to turn the call to Joshua Higa, Vice President of Investor Relations.Speaker12Thank you. We've issued a press r ...